Osteoporosis Trial, Recruiting NCT02635022 Sponsor: National Taiwan University Hospital Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT02635022
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 50 or older who also meet at least one of the following conditions:
  • People who have recently had a hip fracture and are being treated in an orthopaedic ward
  • People in a geriatric ward where an X-ray has newly identified a spinal (vertebral) fracture, or people attending an outpatient clinic with a newly identified spinal fracture causing symptoms
  • People who have recently been started on osteoporosis medications for the first time
  • People whose osteoporosis medications have recently been changed
  • People who have been having difficulty taking their osteoporosis medications as prescribed
  • People whose treating doctor believes they would benefit from extra support in managing their osteoporosis and medications

Who may not be able to join:

  • People whose life expectancy is estimated to be less than 2 years, or people who cannot be assessed due to communication difficulties
  • People whose fracture is classified as an "atypical" fracture (confirm with trial site for clarification on what this means in this context)
  • People who are already taking part in another clinical trial involving medications
  • People who are not willing to participate in the assessments and treatment involved in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ding-Cheng Chan, MD, PhD, National Taiwan University Hospital, Chutung branch

Phone: 886-2-23123456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2015
Est. completion
1 December 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Changes of medication adherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov